Healthcare Advocacy Across the Northeast
Lanton Strategies represents healthcare providers, hospitals, health systems, biotechnology companies, pharmaceutical manufacturers and industry associations before state legislatures and regulatory agencies across the Northeast. Learn how our government affairs services help organizations address legislation, rulemaking and policies affecting their businesses.
340B Rebates: Who Bears the Cost of Changing How the Program Works?
HRSA's revised 340B rebate pilot raises new questions about drug purchasing, cash flow, transaction verification and administrative costs. This article examines the concerns of manufacturers and hospitals, the pilot's regulatory safeguards, and the financial, legal and operational considerations facing covered entities, pharmacies and their service providers.